Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety of IV Diclofenac (DIC075V) for Pain After Abdominal or Pelvic Surgery

ClinicalTrials.gov ID: NCT00448110

Public ClinicalTrials.gov record NCT00448110. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 11:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Active- and Placebo-Controlled Study of the Efficacy and Safety of Repeated Dosing of DIC075V Relative To Parenteral Ketorolac and Placebo in Patients With Acute Post-Op Pain After Abdominal or Pelvic Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will compare repeated intermittent IV dosing of diclofenac in patients with moderate to severe post-surgical pain from abdominal or pelvic surgery.

Study identification

NCT ID
NCT00448110
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Javelin Pharmaceuticals
Industry
Enrollment
331 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2006 (Type not available)
Primary completion
Nov 2007 (Actual)
Completion
Nov 2007 (Actual)
Last update posted
May 22, 2009

2006 – 2007

United States locations

U.S. sites
14
U.S. states
8
U.S. cities
14
Facility City State ZIP Site status
Alabama Clinical Therapeutics Birmingham Alabama 35235 —
Eliza Coffee Memorial Hospital Florence Alabama 35630 —
Drug Research and Analysis Corp. Montgomery Alabama 36106 —
Helen Keller Hospital Sheffield Alabama 35660 —
Teton Research / Parkview Surgical Little Rock Arkansas 72205 —
Glendale Adventist Medical Center Glendale California 91206 —
Saddleback Memorial Medical Center Laguna Hills California 92653 —
Visions Clinical Research Boynton Beach Florida 33437 —
Duke University Medical Center Durham North Carolina 27710 —
Clinical Research Services Bismarck North Dakota 58501 —
Clinical Research Center Austin Texas 78705 —
Memorial Hermann Healthcare System - Memorial City Hospital Houston Texas 77024 —
Clinical Research Center San Marcos Texas 78666 —
Jean Brown Research Salt Lake City Utah 84124 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00448110, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 22, 2009 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00448110 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →